-
1.
公开(公告)号:EP0836605B1
公开(公告)日:2002-02-06
申请号:EP96923893.0
申请日:1996-06-24
IPC分类号: C07D487/04 , C07D471/14 , A61K31/505 , C07D207/34 , C07D471/04
CPC分类号: C07D471/14 , C07D207/34 , C07D487/04
-
公开(公告)号:EP1153024A1
公开(公告)日:2001-11-14
申请号:EP00916840.2
申请日:2000-02-16
发明人: IMBACH, Patricia , CAPRARO, Hans-Georg , ZIMMERMANN, Jürg , CARAVATTI, Giorgio , FURET, Pascal , BRILL, Wolfgang, Karl-Diether
IPC分类号: C07D473/16 , C07D473/40 , A61K31/52 , A61P35/00
CPC分类号: C07D473/16 , C07D473/40
摘要: 2-Amino-6-anilino-purine derivatives of formula (I) in which R1 is -S(O)k-NR6R7 or-N(aryl lower alkyl) carbamoyl or -NH-S(O)i-R8 or -NH-C(O)-R9; 9 is 1-5; These compounds inhibit p34cdc2/cyclin Bcdc13 kinase and protein tyrosine kinase pp60c-src and can be used for treatment of hyperproliferative diseases, for example tumour diseases, and diseases which respond to inhibition of the activity of protein tyrosine kinase pp60c-src, in particular osteoporosis.
-
公开(公告)号:EP1153024B1
公开(公告)日:2004-04-28
申请号:EP00916840.2
申请日:2000-02-16
申请人: Novartis AG , Novartis Pharma GmbH
发明人: IMBACH, Patricia , CAPRARO, Hans-Georg , ZIMMERMANN, Jürg , CARAVATTI, Giorgio , FURET, Pascal , BRILL, Wolfgang, Karl-Diether
IPC分类号: C07D473/16 , C07D473/40 , A61K31/52 , A61P35/00
CPC分类号: C07D473/16 , C07D473/40
摘要: 2-Amino-6-anilino-purine derivatives of formula (I) in which R1 is -S(O)k-NR6R7 or-N(aryl lower alkyl) carbamoyl or -NH-S(O)i-R8 or -NH-C(O)-R9; 9 is 1-5; These compounds inhibit p34cdc2/cyclin Bcdc13 kinase and protein tyrosine kinase pp60c-src and can be used for treatment of hyperproliferative diseases, for example tumour diseases, and diseases which respond to inhibition of the activity of protein tyrosine kinase pp60c-src, in particular osteoporosis.
-
4.
公开(公告)号:EP0836605A1
公开(公告)日:1998-04-22
申请号:EP96923893.0
申请日:1996-06-24
申请人: Novartis AG
CPC分类号: C07D471/14 , C07D207/34 , C07D487/04
摘要: Described are 7H-pyrrolo[2,3-d]pyrimidine derivatives of formula (I) wherein the symbols are as defined in claim 1. Those compounds inhibit tyrosine protein kinase and can be used in the treatment of hyperproliferative diseases, for example tumour diseases.
-
-
-